Home > Service > Drug development > In vitro DMPK study
  • Assessment of the ability to penetrate the blood-brain barrier

  • Metabolic stability (microsomes/S9/hepatocytes/plasma))

  • P450 enzyme inhibition (including TDI)

  • P450 enzyme inductio

  • P450 Enzyme Phenotyping (Recombinase/Chemical Inhibitors)

  • Protein binding (plasma/tissue/microsome)

  • Red blood cell/plasma partition ratio

  • Caco-2 permeability

  •  (P-gp/BCRP/OATs/OCTs/OATPs) / • Efflux and uptake transporters (P-gp/BCRP/OATs/OCTs/OATPs) 

  • In vitro metabolite identification

  • Capture of GSH reactive metabolites